These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1835341

  • 21. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [Abstract] [Full Text] [Related]

  • 22. [Phase I clinical study of zinostatin stimalamer (YM 881) by intravenous injection].
    Saito T, Nakao I, Wakui A, Kurihara M, Niitani H, Konno T, Tsukagoshi S, Maeda H.
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1311-8. PubMed ID: 1829882
    [Abstract] [Full Text] [Related]

  • 23. [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].
    Taguchi T, Saito T, Ota J, Nakao I, Ohashi K, Nakamura H, Konno T.
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1665-75. PubMed ID: 1714707
    [Abstract] [Full Text] [Related]

  • 24. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma.
    Okusaka T, Okada S, Ishii H, Ikeda M, Nakasuka H, Nagahama H, Iwata R, Furukawa H, Takayasu K, Nakanishi Y, Sakamoto M, Hirohashi S, Yoshimori M.
    Oncology; 1998 Aug; 55(4):276-83. PubMed ID: 9663415
    [Abstract] [Full Text] [Related]

  • 25. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
    Kobayashi M, Imai K, Sugihara S, Maeda H, Konno T, Yamanaka H.
    Urology; 1991 Mar; 37(3):288-94. PubMed ID: 1848030
    [Abstract] [Full Text] [Related]

  • 26. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
    Konno T, Oda T, Nagamitsu A, Tabaru K, Yamashita R, Kai Y.
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
    [Abstract] [Full Text] [Related]

  • 27. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer].
    Ohtsuka N, Konno T.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992
    [Abstract] [Full Text] [Related]

  • 28. Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.
    Ikeda K, Saitoh S, Suzuki Y, Tsubota A, Koida I, Kobayashi M, Arase Y, Chayama K, Murashima N, Kumada H.
    J Gastroenterol; 1997 Aug; 32(4):513-20. PubMed ID: 9250900
    [Abstract] [Full Text] [Related]

  • 29. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
    Maeda H.
    Adv Drug Deliv Rev; 2001 Mar 01; 46(1-3):169-85. PubMed ID: 11259839
    [Abstract] [Full Text] [Related]

  • 30. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 31. [Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma].
    Konno T, Maeda H, Yokoyama I, Iwai K, Ogata K, Tashiro S, Uemura K, Mochinaga M, Watanabe E, Nakakuma K, Morinaga T, Miyauchi Y.
    Gan To Kagaku Ryoho; 1982 Nov 01; 9(11):2005-15. PubMed ID: 6307179
    [Abstract] [Full Text] [Related]

  • 32. [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors].
    Konno T, Iwai K, Maki S, Tashiro S, Miyauchi Y, Maeda H, Yokoyama I.
    Nihon Geka Gakkai Zasshi; 1984 Sep 01; 85(9):1151-6. PubMed ID: 6095018
    [Abstract] [Full Text] [Related]

  • 33. [Effect of YM 881 (SMANCS) in rats bearing intracerebrally implanted 9L glioma].
    Kuratsu J, Takaki S, Mihara Y, Kochi M, Ushio Y.
    Gan To Kagaku Ryoho; 1991 Aug 01; 18(10):1713-4. PubMed ID: 1831341
    [No Abstract] [Full Text] [Related]

  • 34. SMANCS.
    Duncan R.
    Jpn J Cancer Res; 1995 Jun 01; 86(6):inside front cover. PubMed ID: 7622412
    [No Abstract] [Full Text] [Related]

  • 35. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
    Masuda E, Maeda H.
    Cancer Immunol Immunother; 1995 May 01; 40(5):329-38. PubMed ID: 7600566
    [Abstract] [Full Text] [Related]

  • 36. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
    Yamasaki K, Konno T, Miyauchi Y, Maeda H.
    Gan To Kagaku Ryoho; 1987 May 01; 14(5 Pt 1):1224-8. PubMed ID: 3034169
    [Abstract] [Full Text] [Related]

  • 37. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25 Suppl 1():10-8. PubMed ID: 9512681
    [Abstract] [Full Text] [Related]

  • 38. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 39. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E, Maeda H.
    Cancer Res; 1996 Apr 15; 56(8):1868-73. PubMed ID: 8620506
    [Abstract] [Full Text] [Related]

  • 40. [Computed tomography after administration of SMANCS-lipiodol to liver cancers].
    Maki S, Konno T, Iwai K, Uchida M, Tashiro S, Miyauchi Y, Maeda H.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1443-9. PubMed ID: 6097616
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.